1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. EXELIXIS INC

Exelixis Inc

XNAS: EXEL

Mid-range Performer
Download real time

36.98 0.81 (2.24%)

New 52W High in past week

2.6M XNAS Volume

XNAS 12 May, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Share
21S
2W
3O
1T
10,191.1

Market Cap

High in industry
19.6

PE TTM

High in industry
0.1

PEG TTM

PEG TTM is less than 1
4.5

Price to Book

Below industry Median
0.2

Beta 1Year

Very Low volatility
Board Meeting
The next board meeting for Exelixis Inc is on 20 May 2025 for the purpose of BofA Securities 2025 Health Care Conference See details

Exelixis Inc - EXEL - stock price prediction, stock price target, analyst ratings from 20 analysts

Exelixis Inc has a share price target of US$ 38, revenue growth forecast of 3.9%, and profit growth estimate of 12.2% for FY25, based on top 20 analyst calls.

Forecaster Screeners